Granules India
Granules India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Granules India
Start SIPGranules India Investment Rating
-
Master Rating:
-
Granules India has an operating revenue of Rs. 4,511.92 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 15% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 1,014 | 1,032 | 964 | 921 | 913 |
| Operating Expenses Qtr Cr | 797 | 794 | 778 | 725 | 707 |
| Operating Profit Qtr Cr | 217 | 239 | 186 | 197 | 206 |
| Depreciation Qtr Cr | 38 | 38 | 35 | 35 | 32 |
| Interest Qtr Cr | 14 | 12 | 8 | 4 | 4 |
| Tax Qtr Cr | 43 | 48 | 37 | 37 | 45 |
| Net Profit Qtr Cr | 125 | 140 | 109 | 125 | 129 |
Granules India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹285.28
- 50 Day
- ₹290.07
- 100 Day
- ₹296.51
- 200 Day
- ₹303.39
- 20 Day
- ₹286.68
- 50 Day
- ₹290.92
- 100 Day
- ₹293.74
- 200 Day
- ₹314.46
Granules India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹284.29 |
| Second Resistance | ₹286.62 |
| Third Resistance | ₹288.84 |
| RSI | 51.42 |
| MFI | 26.43 |
| MACD Single Line | -4.05 |
| MACD | -3.7 |
| Support | |
|---|---|
| First Resistance | ₹279.74 |
| Second Resistance | ₹277.52 |
| Third Resistance | ₹275.19 |
Granules India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,301,380 | 58,991,555 | 45.33 |
| Week | 954,741 | 40,882,027 | 42.82 |
| 1 Month | 1,478,557 | 51,158,063 | 34.6 |
| 6 Month | 954,253 | 32,349,193 | 33.9 |
Granules India Result Highlights
Granules India Synopsis
NSE-Medical-Diversified
Granules India L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3931.20 Cr. and Equity Capital is Rs. 24.20 Cr. for the Year ended 31/03/2023. Granules India Ltd. is a Public Limited Listed company incorporated on 18/03/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1991PLC012471 and registration number is 012471.| Market Cap | 6,966 |
| Sales | 3,931 |
| Shares in Float | 14.04 |
| No of funds | 185 |
| Yield | 0.53 |
| Book Value | 2.53 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | 6 |
| Alpha | -0.01 |
| Beta | 1.11 |
Granules India
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 42.02% | 42.02% | 41.93% | 41.98% |
| Mutual Funds | 3.76% | 3.91% | 3.48% | 3.03% |
| Insurance Companies | 1.27% | 0.84% | 0.84% | |
| Foreign Portfolio Investors | 23.9% | 23.66% | 22.35% | 23.13% |
| Individual Investors | 21.14% | 20.74% | 21.72% | 25.25% |
| Others | 7.91% | 8.83% | 9.68% | 6.61% |
Granules India Management
| Name | Designation |
|---|---|
| Mr. Krishna Prasad Chigurupati | Chairman & Managing Director |
| Dr. K V S Ram Rao | Joint Managing Director & CEO |
| Mrs. Uma Devi Chigurupati | Executive Director |
| Mr. Harsha Chigurupati | Executive Director |
| Mr. K B Sankar Rao | Non Exe.Non Ind.Director |
| Mr. Arun Rao Akinepally | Ind. Non-Executive Director |
| Mr. Arun Sawhney | Ind. Non-Executive Director |
| Mr. Robert George Cunard | Ind. Non-Executive Director |
| Dr. Saumen Chakraborty | Ind. Non-Executive Director |
| Mrs. Sucharita Rao Palepu | Ind. Non-Executive Director |
Granules India Forecast
Price Estimates
Granules India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-16 | Audited Results & Final Dividend | |
| 2023-01-24 | Quarterly Results | |
| 2022-10-20 | Quarterly Results | |
| 2022-08-09 | Quarterly Results & Buy Back of Shares | |
| 2022-05-18 | Audited Results & Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-08-03 | FINAL | Rs.1.50 per share(150%)Final Dividend |
| 2022-02-18 | INTERIM | Re.0.25 per share (25%) Third Interim Dividend |
| 2021-11-25 | INTERIM | Re.0.25 per share (25%) Second Interim Dividend |
| 2021-08-06 | INTERIM | Rs.0.25 per share(25%)First Interim Dividend |
| 2021-02-09 | INTERIM | Rs.0.25 per share (25%) Third Interim Dividend |
Granules India FAQs
What is Share Price of Granules India ?
Granules India share price is ₹288 As on 01 June, 2023 | 18:28
What is the Market Cap of Granules India ?
The Market Cap of Granules India is ₹6972 Cr As on 01 June, 2023 | 18:28
What is the P/E ratio of Granules India ?
The P/E ratio of Granules India is 13.5 As on 01 June, 2023 | 18:28
What is the PB ratio of Granules India ?
The PB ratio of Granules India is 2.5 As on 01 June, 2023 | 18:28